Ensign Peak Advisors, Inc - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 214 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2023. The put-call ratio across all filers is 2.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ensign Peak Advisors, Inc ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$1,413,191
-20.5%
28,1400.0%0.00%
-25.0%
Q2 2023$1,778,448
+40.5%
28,1400.0%0.00%
+33.3%
Q1 2023$1,266,019
+8.9%
28,140
+6.0%
0.00%0.0%
Q4 2022$1,162,717
+17.3%
26,540
+76.5%
0.00%
+50.0%
Q3 2022$991,000
-69.0%
15,040
-76.2%
0.00%
-75.0%
Q2 2022$3,193,000
-29.2%
63,198
-10.5%
0.01%
-11.1%
Q1 2022$4,511,000
-37.9%
70,624
+4.1%
0.01%
-35.7%
Q4 2021$7,264,000
+48.9%
67,814
+42.9%
0.01%
+40.0%
Q3 2021$4,878,000
+81.9%
47,446
+55.6%
0.01%
+100.0%
Q2 2021$2,682,000
-6.5%
30,493
+3.4%
0.01%
-16.7%
Q1 2021$2,868,000
+17.7%
29,493
+35.8%
0.01%0.0%
Q4 2020$2,437,000
+39.8%
21,724
+15.6%
0.01%
+50.0%
Q3 2020$1,743,000
+13.0%
18,799
-4.9%
0.00%0.0%
Q2 2020$1,542,000
+18.9%
19,773
-10.9%
0.00%0.0%
Q1 2020$1,297,000
-29.1%
22,190
-2.8%
0.00%
-20.0%
Q4 2019$1,829,00022,8260.01%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 581,768$25,487,2569.57%
Casdin Capital, LLC 1,477,800$64,742,4185.02%
Nextech Invest Ltd. 188,228$8,246,2693.28%
DAFNA Capital Management LLC 261,235$11,444,7053.22%
Rock Springs Capital Management LP 1,891,510$82,867,0531.99%
HealthCor Management, L.P. 30,000$1,314,3001.20%
EFG Asset Management (North America) Corp. 110,853$4,766,6791.07%
Novo Holdings A/S 370,000$16,209,7001.01%
SECTORAL ASSET MANAGEMENT INC 115,900$5,077,5790.98%
EMERALD MUTUAL FUND ADVISERS TRUST 305,709$13,393,1110.83%
View complete list of BLUEPRINT MEDICINES CORP shareholders